Nurix Therapeutics Inc (NRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 05-2024 | 02-2024 | 11-2023 | 08-2023 | 05-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -86,064 | -41,518 | -143,948 | -101,992 | -65,010 |
| Depreciation Amortization | 7,979 | 3,888 | 8,233 | 6,444 | 4,705 |
| Accounts receivable | 0 | N/A | N/A | -2,000 | N/A |
| Accounts payable and accrued liabilities | -3,471 | -930 | 1,614 | -3,036 | -1,839 |
| Other Working Capital | -16,149 | -10,213 | 20,121 | -38,699 | -23,916 |
| Other Operating Activity | 16,049 | 6,822 | 32,615 | 31,229 | 19,139 |
| Operating Cash Flow | $-81,656 | $-41,951 | $-81,365 | $-108,054 | $-66,921 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,821 | -2,884 | -8,401 | -5,816 | -3,357 |
| Purchase Of Investment | -279,921 | -54,803 | -246,334 | -157,941 | -83,353 |
| Sale Of Investment | 189,185 | 93,200 | 323,036 | 246,431 | 146,609 |
| Investing Cash Flow | $-95,557 | $35,513 | $68,301 | $82,674 | $59,899 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 239,391 | 1,624 | 3,217 | 3,210 | 1,506 |
| Common Stock Repurchased | -15 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $239,376 | $1,624 | $3,217 | $3,210 | $1,506 |
| Beginning Cash Position | 55,528 | 55,528 | 65,375 | 65,375 | 65,375 |
| End Cash Position | 117,691 | 50,714 | 55,528 | 43,205 | 59,859 |
| Net Cash Flow | $62,163 | $-4,814 | $-9,847 | $-22,170 | $-5,516 |
| Free Cash Flow | |||||
| Operating Cash Flow | -81,656 | -41,951 | -81,365 | -108,054 | -66,921 |
| Capital Expenditure | -4,821 | -2,884 | -8,401 | -5,816 | -3,357 |
| Free Cash Flow | -86,477 | -44,835 | -89,766 | -113,870 | -70,278 |